STING 작용제로서 융합된 헤테로아릴 히드록사메이트
본 발명은 화학식 I로 나타낸 신규한 치환된 이종환식 화합물, 또는 이들의 약제학적으로 허용가능한 염, 용매화물, 다형체, 에스테르, 호변이성질체 또는 전구약물, 및 이러한 화합물을 포함하는 조성물을 제공한다. 제공된 화합물은 인터페론 유전자의 자극제(STING)의작용제로서 사용될 수있으며, 암 및 특정한 감염성 질환의 치료에 유용하다. [화학식 I] JPEGpct00100.jpg6352 The invention provides novel substituted heterocyclic compounds represented by th...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | kor |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | JEON SUNHWA JEON SEEUN LEE JINWOO YANG INHO KIM SUNJOO LEE JUNGWOO YOON CHEOLHWAN HAN CHEOLKYU SHIN YOUNGDO KANG BYUNGNAM SEO JEONGBEOB KANG HONGJUN |
| description | 본 발명은 화학식 I로 나타낸 신규한 치환된 이종환식 화합물, 또는 이들의 약제학적으로 허용가능한 염, 용매화물, 다형체, 에스테르, 호변이성질체 또는 전구약물, 및 이러한 화합물을 포함하는 조성물을 제공한다. 제공된 화합물은 인터페론 유전자의 자극제(STING)의작용제로서 사용될 수있으며, 암 및 특정한 감염성 질환의 치료에 유용하다. [화학식 I] JPEGpct00100.jpg6352
The invention provides novel substituted heterocyclic compounds represented by the Formulas I, or a pharmaceutically acceptable salt, solvate, polymorph, ester, tautomer or prodrug thereof, and a composition comprising these compounds. The compounds provided can be used as agonists of Stimulator of Interferon Genes (STING) and are useful in the treatment of cancers and certain infectious diseases. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_KR20240115324A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>KR20240115324A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_KR20240115324A3</originalsourceid><addsrcrecordid>eNrjZHANDvH0c1d4M2_im1kr3yyY83rhnDctcxTezNn6durK1xPmKLydvuRtaw9IeGrL62VbFN7O63g9Gahs7pumNa9XTnkzd8vbrh08DKxpiTnFqbxQmptB2c01xNlDN7UgPz61uCAxOTUvtSTeO8jIwMjEwNDQ1NjIxNGYOFUAu9BGvg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>STING 작용제로서 융합된 헤테로아릴 히드록사메이트</title><source>esp@cenet</source><creator>JEON SUNHWA ; JEON SEEUN ; LEE JINWOO ; YANG INHO ; KIM SUNJOO ; LEE JUNGWOO ; YOON CHEOLHWAN ; HAN CHEOLKYU ; SHIN YOUNGDO ; KANG BYUNGNAM ; SEO JEONGBEOB ; KANG HONGJUN</creator><creatorcontrib>JEON SUNHWA ; JEON SEEUN ; LEE JINWOO ; YANG INHO ; KIM SUNJOO ; LEE JUNGWOO ; YOON CHEOLHWAN ; HAN CHEOLKYU ; SHIN YOUNGDO ; KANG BYUNGNAM ; SEO JEONGBEOB ; KANG HONGJUN</creatorcontrib><description>본 발명은 화학식 I로 나타낸 신규한 치환된 이종환식 화합물, 또는 이들의 약제학적으로 허용가능한 염, 용매화물, 다형체, 에스테르, 호변이성질체 또는 전구약물, 및 이러한 화합물을 포함하는 조성물을 제공한다. 제공된 화합물은 인터페론 유전자의 자극제(STING)의작용제로서 사용될 수있으며, 암 및 특정한 감염성 질환의 치료에 유용하다. [화학식 I] JPEGpct00100.jpg6352
The invention provides novel substituted heterocyclic compounds represented by the Formulas I, or a pharmaceutically acceptable salt, solvate, polymorph, ester, tautomer or prodrug thereof, and a composition comprising these compounds. The compounds provided can be used as agonists of Stimulator of Interferon Genes (STING) and are useful in the treatment of cancers and certain infectious diseases.</description><language>kor</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240725&DB=EPODOC&CC=KR&NR=20240115324A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25555,76308</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240725&DB=EPODOC&CC=KR&NR=20240115324A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>JEON SUNHWA</creatorcontrib><creatorcontrib>JEON SEEUN</creatorcontrib><creatorcontrib>LEE JINWOO</creatorcontrib><creatorcontrib>YANG INHO</creatorcontrib><creatorcontrib>KIM SUNJOO</creatorcontrib><creatorcontrib>LEE JUNGWOO</creatorcontrib><creatorcontrib>YOON CHEOLHWAN</creatorcontrib><creatorcontrib>HAN CHEOLKYU</creatorcontrib><creatorcontrib>SHIN YOUNGDO</creatorcontrib><creatorcontrib>KANG BYUNGNAM</creatorcontrib><creatorcontrib>SEO JEONGBEOB</creatorcontrib><creatorcontrib>KANG HONGJUN</creatorcontrib><title>STING 작용제로서 융합된 헤테로아릴 히드록사메이트</title><description>본 발명은 화학식 I로 나타낸 신규한 치환된 이종환식 화합물, 또는 이들의 약제학적으로 허용가능한 염, 용매화물, 다형체, 에스테르, 호변이성질체 또는 전구약물, 및 이러한 화합물을 포함하는 조성물을 제공한다. 제공된 화합물은 인터페론 유전자의 자극제(STING)의작용제로서 사용될 수있으며, 암 및 특정한 감염성 질환의 치료에 유용하다. [화학식 I] JPEGpct00100.jpg6352
The invention provides novel substituted heterocyclic compounds represented by the Formulas I, or a pharmaceutically acceptable salt, solvate, polymorph, ester, tautomer or prodrug thereof, and a composition comprising these compounds. The compounds provided can be used as agonists of Stimulator of Interferon Genes (STING) and are useful in the treatment of cancers and certain infectious diseases.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZHANDvH0c1d4M2_im1kr3yyY83rhnDctcxTezNn6durK1xPmKLydvuRtaw9IeGrL62VbFN7O63g9Gahs7pumNa9XTnkzd8vbrh08DKxpiTnFqbxQmptB2c01xNlDN7UgPz61uCAxOTUvtSTeO8jIwMjEwNDQ1NjIxNGYOFUAu9BGvg</recordid><startdate>20240725</startdate><enddate>20240725</enddate><creator>JEON SUNHWA</creator><creator>JEON SEEUN</creator><creator>LEE JINWOO</creator><creator>YANG INHO</creator><creator>KIM SUNJOO</creator><creator>LEE JUNGWOO</creator><creator>YOON CHEOLHWAN</creator><creator>HAN CHEOLKYU</creator><creator>SHIN YOUNGDO</creator><creator>KANG BYUNGNAM</creator><creator>SEO JEONGBEOB</creator><creator>KANG HONGJUN</creator><scope>EVB</scope></search><sort><creationdate>20240725</creationdate><title>STING 작용제로서 융합된 헤테로아릴 히드록사메이트</title><author>JEON SUNHWA ; JEON SEEUN ; LEE JINWOO ; YANG INHO ; KIM SUNJOO ; LEE JUNGWOO ; YOON CHEOLHWAN ; HAN CHEOLKYU ; SHIN YOUNGDO ; KANG BYUNGNAM ; SEO JEONGBEOB ; KANG HONGJUN</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_KR20240115324A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>kor</language><creationdate>2024</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>JEON SUNHWA</creatorcontrib><creatorcontrib>JEON SEEUN</creatorcontrib><creatorcontrib>LEE JINWOO</creatorcontrib><creatorcontrib>YANG INHO</creatorcontrib><creatorcontrib>KIM SUNJOO</creatorcontrib><creatorcontrib>LEE JUNGWOO</creatorcontrib><creatorcontrib>YOON CHEOLHWAN</creatorcontrib><creatorcontrib>HAN CHEOLKYU</creatorcontrib><creatorcontrib>SHIN YOUNGDO</creatorcontrib><creatorcontrib>KANG BYUNGNAM</creatorcontrib><creatorcontrib>SEO JEONGBEOB</creatorcontrib><creatorcontrib>KANG HONGJUN</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>JEON SUNHWA</au><au>JEON SEEUN</au><au>LEE JINWOO</au><au>YANG INHO</au><au>KIM SUNJOO</au><au>LEE JUNGWOO</au><au>YOON CHEOLHWAN</au><au>HAN CHEOLKYU</au><au>SHIN YOUNGDO</au><au>KANG BYUNGNAM</au><au>SEO JEONGBEOB</au><au>KANG HONGJUN</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>STING 작용제로서 융합된 헤테로아릴 히드록사메이트</title><date>2024-07-25</date><risdate>2024</risdate><abstract>본 발명은 화학식 I로 나타낸 신규한 치환된 이종환식 화합물, 또는 이들의 약제학적으로 허용가능한 염, 용매화물, 다형체, 에스테르, 호변이성질체 또는 전구약물, 및 이러한 화합물을 포함하는 조성물을 제공한다. 제공된 화합물은 인터페론 유전자의 자극제(STING)의작용제로서 사용될 수있으며, 암 및 특정한 감염성 질환의 치료에 유용하다. [화학식 I] JPEGpct00100.jpg6352
The invention provides novel substituted heterocyclic compounds represented by the Formulas I, or a pharmaceutically acceptable salt, solvate, polymorph, ester, tautomer or prodrug thereof, and a composition comprising these compounds. The compounds provided can be used as agonists of Stimulator of Interferon Genes (STING) and are useful in the treatment of cancers and certain infectious diseases.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | kor |
| recordid | cdi_epo_espacenet_KR20240115324A |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | STING 작용제로서 융합된 헤테로아릴 히드록사메이트 |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T18%3A33%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=JEON%20SUNHWA&rft.date=2024-07-25&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EKR20240115324A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |